LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, et al. Mov Disord 2023 Feb 18. doi: 10.1002/mds.29297.

Read + Share

Amedeo Smart

Independent Medical Education

Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, et al. LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease. Mov Disord 2023 Feb 18. doi: 10.1002/mds.29297.
PMID: 36807624